{"transactions":[{"id":1851907,"issuer":{"id":7510,"kind":"organization","name":"FEMASYS INC"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:41:10.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in annual one-third (1/3) increments over a three (3) year period beginning on June 14, 2024, assuming continued service."}],"balance_after":17000,"derivative":{"exercise_price":0.64,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001140361-23-030281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036123030281/form4.xml","form_type":"4"}},{"id":2335281,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-14T11:24:23.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":375000,"derivative":{"exercise_price":2.55,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001214659-22-003894","document":"marketforms-55758.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465922003894/marketforms-55758.xml","form_type":"4"}},{"id":2587967,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-08-27T13:39:28.000Z","date":"2021-08-26","kind":"gift","acquired":true,"shares":1000,"ownership":{"direct":false,"nature":"Custodian of UTMA account for Anna Kendall"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 26, 2021, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild Anna Kendall, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account. The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"shares","element":"transactionShares","label":"F1","text":"On August 26, 2021, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild Anna Kendall, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account. The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001214659-21-009051","document":"marketforms-53684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465921009051/marketforms-53684.xml","form_type":"4"}},{"id":2587966,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-08-27T13:39:28.000Z","date":"2021-08-26","kind":"gift","acquired":false,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 26, 2021, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild Anna Kendall, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account. The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"shares","element":"transactionShares","label":"F1","text":"On August 26, 2021, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild Anna Kendall, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account. The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":636149,"source":{"system":"sec-edgar","filing":"0001214659-21-009051","document":"marketforms-53684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465921009051/marketforms-53684.xml","form_type":"4"}},{"id":2789061,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-15T17:10:39.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":250000,"derivative":{"exercise_price":5.3,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001214659-21-003150","document":"marketforms-51878.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465921003150/marketforms-51878.xml","form_type":"4"}},{"id":2925387,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-01-04T16:05:14.000Z","date":"2020-12-30","kind":"gift","acquired":true,"shares":1000,"ownership":{"direct":false,"nature":"Custodian of UTMA account for William Kendall Conner"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild William Kendall Conner, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account.  The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"shares","element":"transactionShares","label":"F3","text":"On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild William Kendall Conner, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account.  The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001214659-21-000034","document":"marketforms-50806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465921000034/marketforms-50806.xml","form_type":"4"}},{"id":2925386,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-01-04T16:05:14.000Z","date":"2020-12-30","kind":"gift","acquired":false,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild William Kendall Conner, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account.  The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"shares","element":"transactionShares","label":"F3","text":"On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild William Kendall Conner, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account.  The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":637149,"source":{"system":"sec-edgar","filing":"0001214659-21-000034","document":"marketforms-50806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465921000034/marketforms-50806.xml","form_type":"4"}},{"id":2925385,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-01-04T16:05:14.000Z","date":"2020-12-30","kind":"gift","acquired":true,"shares":1000,"ownership":{"direct":false,"nature":"Custodian of UTMA account for Colin Kendall"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild Colin Kendall, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account.  The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"shares","element":"transactionShares","label":"F1","text":"On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild Colin Kendall, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account.  The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001214659-21-000034","document":"marketforms-50806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465921000034/marketforms-50806.xml","form_type":"4"}},{"id":2925384,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-01-04T16:05:14.000Z","date":"2020-12-30","kind":"gift","acquired":false,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild Colin Kendall, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account.  The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"shares","element":"transactionShares","label":"F1","text":"On December 30, 2020, the reporting person gifted these shares to a Uniform Gift to Minors Act custodial account for the benefit of the reporting person's grandchild Colin Kendall, for no consideration and for which the reporting person is the custodian. The reporting person may be deemed to have acquired indirect beneficial ownership of such shares upon gifting them to the custodial account.  The reporting person disclaims beneficial ownership of the shares held by his grandchild."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":638149,"source":{"system":"sec-edgar","filing":"0001214659-21-000034","document":"marketforms-50806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465921000034/marketforms-50806.xml","form_type":"4"}},{"id":3091467,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2020-07-02T16:00:27.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-06-30","underlying":"Common Stock","underlying_shares":333},"source":{"system":"sec-edgar","filing":"0001214659-20-006104","document":"marketforms-49164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920006104/marketforms-49164.xml","form_type":"4"}},{"id":3091466,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-07-02T16:00:27.000Z","date":"2020-06-30","kind":"tax_withholding","acquired":false,"shares":148,"price":4.86,"value":719.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":639149,"source":{"system":"sec-edgar","filing":"0001214659-20-006104","document":"marketforms-49164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920006104/marketforms-49164.xml","form_type":"4"}},{"id":3091465,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-07-02T16:00:27.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":639297,"source":{"system":"sec-edgar","filing":"0001214659-20-006104","document":"marketforms-49164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920006104/marketforms-49164.xml","form_type":"4"}},{"id":3120181,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-06-05T16:05:17.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":50000,"price":5.1062,"value":255310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 18, 2020 in order to satisfy the tax obligations of the reporting person resulting from the (i) conversion of the reporting person's then existing performance-based equity interests in the Company to shares of common stock of the Company in connection with the Company's Initial Public Offering in 2018, and (ii) vesting of shares of restricted stock issued to the reporting person by the Company pursuant to the reporting person's employment agreement with the Company."}],"balance_after":638964,"source":{"system":"sec-edgar","filing":"0001214659-20-005427","document":"marketforms-48972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920005427/marketforms-48972.xml","form_type":"4"}},{"id":3126754,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2020-06-02T17:13:00.000Z","date":"2020-05-31","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-05-31","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-20-005338","document":"marketforms-48933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920005338/marketforms-48933.xml","form_type":"4"}},{"id":3126753,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-06-02T17:13:00.000Z","date":"2020-05-31","kind":"tax_withholding","acquired":false,"shares":6492,"price":4.87,"value":31616.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":688964,"source":{"system":"sec-edgar","filing":"0001214659-20-005338","document":"marketforms-48933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920005338/marketforms-48933.xml","form_type":"4"}},{"id":3126752,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-06-02T17:13:00.000Z","date":"2020-05-31","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":695456,"source":{"system":"sec-edgar","filing":"0001214659-20-005338","document":"marketforms-48933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920005338/marketforms-48933.xml","form_type":"4"}},{"id":3186248,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2020-04-02T16:16:18.000Z","date":"2020-03-31","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":333,"derivative":{"exercise_price":0,"exercise_date":"2020-03-31","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-20-003146","document":"marketforms-48494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920003146/marketforms-48494.xml","form_type":"4"}},{"id":3186247,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-04-02T16:16:18.000Z","date":"2020-03-31","kind":"tax_withholding","acquired":false,"shares":99,"price":2.19,"value":216.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":680884,"source":{"system":"sec-edgar","filing":"0001214659-20-003146","document":"marketforms-48494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920003146/marketforms-48494.xml","form_type":"4"}},{"id":3186246,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-04-02T16:16:18.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":680983,"source":{"system":"sec-edgar","filing":"0001214659-20-003146","document":"marketforms-48494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920003146/marketforms-48494.xml","form_type":"4"}},{"id":3202294,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-18T16:46:31.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries."}],"balance_after":225000,"derivative":{"exercise_price":1.54,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001214659-20-002749","document":"marketforms-48348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920002749/marketforms-48348.xml","form_type":"4"}},{"id":3231796,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T19:37:51.000Z","date":"2020-02-29","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":14572,"derivative":{"exercise_price":0,"exercise_date":"2020-02-29","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-20-002183","document":"marketforms-48059.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920002183/marketforms-48059.xml","form_type":"4"}},{"id":3231795,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-03-03T19:37:51.000Z","date":"2020-02-29","kind":"tax_withholding","acquired":false,"shares":4729,"price":3.73,"value":17639.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":680654,"source":{"system":"sec-edgar","filing":"0001214659-20-002183","document":"marketforms-48059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920002183/marketforms-48059.xml","form_type":"4"}},{"id":3231794,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-03-03T19:37:51.000Z","date":"2020-02-29","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":685383,"source":{"system":"sec-edgar","filing":"0001214659-20-002183","document":"marketforms-48059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920002183/marketforms-48059.xml","form_type":"4"}},{"id":3246122,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-02-26T16:20:14.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":149,"price":5.82,"value":867.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed solely to amend the number of withheld shares due to a mistake in the number of shares withheld upon vesting of RSUs as reported in the original Form 4 filed on January 2, 2020."}],"balance_after":670811,"source":{"system":"sec-edgar","filing":"0001214659-20-001882","document":"marketforms-47921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920001882/marketforms-47921.xml","form_type":"4/A","original_submission_date":"2020-01-02"}},{"id":3246121,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-02-26T16:05:21.000Z","date":"2019-11-30","kind":"tax_withholding","acquired":false,"shares":6597,"price":7.79,"value":51390.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed solely to amend the number of withheld shares due to a mistake in the number of shares withheld upon vesting of RSUs as reported in the original Form 4 filed on December 2, 2019."}],"balance_after":670631,"source":{"system":"sec-edgar","filing":"0001214659-20-001860","document":"marketforms-47922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920001860/marketforms-47922.xml","form_type":"4/A","original_submission_date":"2019-12-02"}},{"id":3326995,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2020-01-02T14:04:12.000Z","date":"2019-12-31","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":662,"derivative":{"exercise_price":0,"exercise_date":"2019-12-31","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-20-000018","document":"marketforms-47053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920000018/marketforms-47053.xml","form_type":"4"}},{"id":3326994,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-01-02T14:04:12.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":329,"price":5.82,"value":1914.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":662656,"source":{"system":"sec-edgar","filing":"0001214659-20-000018","document":"marketforms-47053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920000018/marketforms-47053.xml","form_type":"4"}},{"id":3326993,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-01-02T14:04:12.000Z","date":"2019-12-31","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":662985,"source":{"system":"sec-edgar","filing":"0001214659-20-000018","document":"marketforms-47053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465920000018/marketforms-47053.xml","form_type":"4"}},{"id":3355764,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2019-12-02T16:56:31.000Z","date":"2019-11-30","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":29144,"derivative":{"exercise_price":0,"exercise_date":"2019-11-30","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-19-007536","document":"marketforms-46719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919007536/marketforms-46719.xml","form_type":"4"}},{"id":3355763,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-12-02T16:56:31.000Z","date":"2019-11-30","kind":"tax_withholding","acquired":false,"shares":14572,"price":7.79,"value":113515.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":662656,"source":{"system":"sec-edgar","filing":"0001214659-19-007536","document":"marketforms-46719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919007536/marketforms-46719.xml","form_type":"4"}},{"id":3355762,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-12-02T16:56:31.000Z","date":"2019-11-30","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":677228,"source":{"system":"sec-edgar","filing":"0001214659-19-007536","document":"marketforms-46719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919007536/marketforms-46719.xml","form_type":"4"}},{"id":3400853,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2019-10-02T16:33:19.000Z","date":"2019-09-30","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":991,"derivative":{"exercise_price":0,"exercise_date":"2019-09-30","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-19-006187","document":"marketforms-45873.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919006187/marketforms-45873.xml","form_type":"4"}},{"id":3400852,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-10-02T16:33:19.000Z","date":"2019-09-30","kind":"tax_withholding","acquired":false,"shares":150,"price":3.18,"value":477.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":662656,"source":{"system":"sec-edgar","filing":"0001214659-19-006187","document":"marketforms-45873.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919006187/marketforms-45873.xml","form_type":"4"}},{"id":3400851,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-10-02T16:33:19.000Z","date":"2019-09-30","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":662806,"source":{"system":"sec-edgar","filing":"0001214659-19-006187","document":"marketforms-45873.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919006187/marketforms-45873.xml","form_type":"4"}},{"id":3424842,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2019-09-03T18:09:22.000Z","date":"2019-08-31","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":43716,"derivative":{"exercise_price":0,"exercise_date":"2019-08-31","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-19-005619","document":"marketforms-45657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919005619/marketforms-45657.xml","form_type":"4"}},{"id":3424841,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-09-03T18:09:22.000Z","date":"2019-08-31","kind":"tax_withholding","acquired":false,"shares":6676,"price":3.8,"value":25368.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":662477,"source":{"system":"sec-edgar","filing":"0001214659-19-005619","document":"marketforms-45657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919005619/marketforms-45657.xml","form_type":"4"}},{"id":3424840,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-09-03T18:09:22.000Z","date":"2019-08-31","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":669153,"source":{"system":"sec-edgar","filing":"0001214659-19-005619","document":"marketforms-45657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919005619/marketforms-45657.xml","form_type":"4"}},{"id":3433085,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-08-20T16:30:12.000Z","date":"2019-08-14","kind":"purchase","acquired":true,"shares":1000,"price":3.65,"value":3650.0,"ownership":{"direct":true},"balance_after":654581,"source":{"system":"sec-edgar","filing":"0001214659-19-005387","document":"marketforms-45524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919005387/marketforms-45524.xml","form_type":"4"}},{"id":3433084,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-08-20T16:30:12.000Z","date":"2019-08-14","kind":"purchase","acquired":true,"shares":1000,"price":3.697,"value":3697.0,"ownership":{"direct":true},"balance_after":653581,"source":{"system":"sec-edgar","filing":"0001214659-19-005387","document":"marketforms-45524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919005387/marketforms-45524.xml","form_type":"4"}},{"id":3433083,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-08-20T16:30:12.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":1000,"price":4.045,"value":4045.0,"ownership":{"direct":true},"balance_after":652581,"source":{"system":"sec-edgar","filing":"0001214659-19-005387","document":"marketforms-45524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919005387/marketforms-45524.xml","form_type":"4"}},{"id":3433082,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-08-20T16:30:12.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":2000,"price":3.995,"value":7990.0,"ownership":{"direct":true},"balance_after":651581,"source":{"system":"sec-edgar","filing":"0001214659-19-005387","document":"marketforms-45524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919005387/marketforms-45524.xml","form_type":"4"}},{"id":3433081,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-08-20T16:30:12.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":1000,"price":3.925,"value":3925.0,"ownership":{"direct":true},"balance_after":649581,"source":{"system":"sec-edgar","filing":"0001214659-19-005387","document":"marketforms-45524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919005387/marketforms-45524.xml","form_type":"4"}},{"id":3433080,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-08-20T16:30:12.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":2000,"price":3.84,"value":7680.0,"ownership":{"direct":true},"balance_after":648581,"source":{"system":"sec-edgar","filing":"0001214659-19-005387","document":"marketforms-45524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919005387/marketforms-45524.xml","form_type":"4"}},{"id":3470976,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2019-07-02T16:30:15.000Z","date":"2019-06-30","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":1320,"derivative":{"exercise_price":0,"exercise_date":"2019-06-30","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-19-004459","document":"marketforms-45277.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919004459/marketforms-45277.xml","form_type":"4"}},{"id":3470975,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-07-02T16:30:15.000Z","date":"2019-06-30","kind":"tax_withholding","acquired":false,"shares":154,"price":4.2,"value":646.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":646581,"source":{"system":"sec-edgar","filing":"0001214659-19-004459","document":"marketforms-45277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919004459/marketforms-45277.xml","form_type":"4"}},{"id":3470974,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-07-02T16:30:15.000Z","date":"2019-06-30","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":646735,"source":{"system":"sec-edgar","filing":"0001214659-19-004459","document":"marketforms-45277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919004459/marketforms-45277.xml","form_type":"4"}},{"id":3504537,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2019-06-03T16:15:12.000Z","date":"2019-05-31","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":58288,"derivative":{"exercise_price":0,"exercise_date":"2019-05-31","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-19-003979","document":"marketforms-45122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919003979/marketforms-45122.xml","form_type":"4"}},{"id":3504536,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-06-03T16:15:12.000Z","date":"2019-05-31","kind":"tax_withholding","acquired":false,"shares":6780,"price":3.72,"value":25221.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":646406,"source":{"system":"sec-edgar","filing":"0001214659-19-003979","document":"marketforms-45122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919003979/marketforms-45122.xml","form_type":"4"}},{"id":3504535,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-06-03T16:15:12.000Z","date":"2019-05-31","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":653186,"source":{"system":"sec-edgar","filing":"0001214659-19-003979","document":"marketforms-45122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919003979/marketforms-45122.xml","form_type":"4"}},{"id":3571844,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2019-04-01T16:40:23.000Z","date":"2019-03-31","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":1649,"derivative":{"exercise_price":0,"exercise_date":"2019-03-31","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-19-002418","document":"marketforms-44722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919002418/marketforms-44722.xml","form_type":"4"}},{"id":3571843,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-04-01T16:40:23.000Z","date":"2019-03-31","kind":"tax_withholding","acquired":false,"shares":263,"price":6.91,"value":1817.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":638614,"source":{"system":"sec-edgar","filing":"0001214659-19-002418","document":"marketforms-44722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919002418/marketforms-44722.xml","form_type":"4"}},{"id":3571842,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-04-01T16:40:23.000Z","date":"2019-03-31","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":638877,"source":{"system":"sec-edgar","filing":"0001214659-19-002418","document":"marketforms-44722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919002418/marketforms-44722.xml","form_type":"4"}},{"id":3618684,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-04T16:46:49.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries."}],"balance_after":325000,"derivative":{"exercise_price":8.05,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0001214659-19-001750","document":"marketforms-44354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919001750/marketforms-44354.xml","form_type":"4"}},{"id":3623013,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T17:24:11.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":72860,"derivative":{"exercise_price":0,"exercise_date":"2019-02-28","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-19-001724","document":"marketforms-44306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919001724/marketforms-44306.xml","form_type":"4"}},{"id":3623012,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-03-01T17:24:11.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":4725,"price":8.05,"value":38036.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":638548,"source":{"system":"sec-edgar","filing":"0001214659-19-001724","document":"marketforms-44306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919001724/marketforms-44306.xml","form_type":"4"}},{"id":3623011,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-03-01T17:24:11.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":643273,"source":{"system":"sec-edgar","filing":"0001214659-19-001724","document":"marketforms-44306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000121465919001724/marketforms-44306.xml","form_type":"4"}},{"id":3708285,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Unit","published_at":"2019-01-03T17:23:36.000Z","date":"2018-12-31","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":1978,"derivative":{"underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001140361-19-000279","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036119000279/form4.xml","form_type":"4"}},{"id":3708284,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-01-03T17:23:36.000Z","date":"2018-12-31","kind":"tax_withholding","acquired":false,"shares":162,"price":6.3,"value":1020.6,"ownership":{"direct":true},"balance_after":628701,"source":{"system":"sec-edgar","filing":"0001140361-19-000279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036119000279/form4.xml","form_type":"4"}},{"id":3708283,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-01-03T17:23:36.000Z","date":"2018-12-31","kind":"exercise","acquired":true,"shares":329,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":628863,"source":{"system":"sec-edgar","filing":"0001140361-19-000279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036119000279/form4.xml","form_type":"4"}},{"id":3743477,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Unit","published_at":"2018-12-04T16:02:51.000Z","date":"2018-11-30","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":87432,"derivative":{"underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001140361-18-044533","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118044533/form4.xml","form_type":"4"}},{"id":3743476,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-12-04T16:02:51.000Z","date":"2018-11-30","kind":"tax_withholding","acquired":false,"shares":7177,"price":8.59,"value":61650.43,"ownership":{"direct":true},"balance_after":628534,"source":{"system":"sec-edgar","filing":"0001140361-18-044533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118044533/form4.xml","form_type":"4"}},{"id":3743475,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-12-04T16:02:51.000Z","date":"2018-11-30","kind":"exercise","acquired":true,"shares":14572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":635711,"source":{"system":"sec-edgar","filing":"0001140361-18-044533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118044533/form4.xml","form_type":"4"}},{"id":3750281,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-11-28T16:01:31.000Z","date":"2018-11-27","kind":"purchase","acquired":true,"shares":1000,"price":9.87,"value":9870.0,"ownership":{"direct":true},"balance_after":621139,"source":{"system":"sec-edgar","filing":"0001140361-18-043897","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118043897/form4.xml","form_type":"4"}},{"id":3752821,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-11-26T13:38:01.000Z","date":"2018-11-23","kind":"purchase","acquired":true,"shares":1950,"price":9.9,"value":19305.0,"ownership":{"direct":true},"balance_after":620139,"source":{"system":"sec-edgar","filing":"0001140361-18-043651","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118043651/form4.xml","form_type":"4"}},{"id":3752820,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-11-26T13:38:01.000Z","date":"2018-11-21","kind":"purchase","acquired":true,"shares":6000,"price":10.17,"value":61020.0,"ownership":{"direct":true},"balance_after":618189,"source":{"system":"sec-edgar","filing":"0001140361-18-043651","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118043651/form4.xml","form_type":"4"}},{"id":3801047,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Unit","published_at":"2018-10-02T16:38:53.000Z","date":"2018-09-30","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":2307,"derivative":{"underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001140361-18-039945","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118039945/form4.xml","form_type":"4"}},{"id":3801046,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-10-02T16:38:53.000Z","date":"2018-09-30","kind":"tax_withholding","acquired":false,"shares":162,"price":17.51,"value":2836.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 396,040 shares of common stock currently issued and outstanding, which are held by Mr. Kendall in constructive trust for his former spouse pursuant to a divorce settlement agreement reached in November 2016 and which will be transferred and come under the control of Mr. Kendall's former spouse in the near future."}],"balance_after":1008229,"source":{"system":"sec-edgar","filing":"0001140361-18-039945","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118039945/form4.xml","form_type":"4"}},{"id":3801045,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-10-02T16:38:53.000Z","date":"2018-09-30","kind":"exercise","acquired":true,"shares":329,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 396,040 shares of common stock currently issued and outstanding, which are held by Mr. Kendall in constructive trust for his former spouse pursuant to a divorce settlement agreement reached in November 2016 and which will be transferred and come under the control of Mr. Kendall's former spouse in the near future."}],"balance_after":1008391,"source":{"system":"sec-edgar","filing":"0001140361-18-039945","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118039945/form4.xml","form_type":"4"}},{"id":3825239,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Unit","published_at":"2018-09-05T17:41:54.000Z","date":"2018-08-31","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":102004,"derivative":{"underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001140361-18-037870","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118037870/form4.xml","form_type":"4"}},{"id":3825238,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-09-05T17:41:54.000Z","date":"2018-08-31","kind":"tax_withholding","acquired":false,"shares":6510,"price":18.01,"value":117245.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 396,040 shares of common stock currently issued and outstanding, which are held by Mr. Kendall in constructive trust for his former spouse pursuant to a divorce settlement agreement reached in November 2016 and which will be transferred and come under the control of Mr. Kendall's former spouse in the near future."}],"balance_after":1008062,"source":{"system":"sec-edgar","filing":"0001140361-18-037870","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118037870/form4.xml","form_type":"4"}},{"id":3825237,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-09-05T17:41:54.000Z","date":"2018-08-31","kind":"exercise","acquired":true,"shares":14572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 396,040 shares of common stock currently issued and outstanding, which are held by Mr. Kendall in constructive trust for his former spouse pursuant to a divorce settlement agreement reached in November 2016 and which will be transferred and come under the control of Mr. Kendall's former spouse in the near future."}],"balance_after":1014572,"source":{"system":"sec-edgar","filing":"0001140361-18-037870","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118037870/form4.xml","form_type":"4"}},{"id":3839840,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Unit","published_at":"2018-08-17T18:40:30.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":2636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":2636,"derivative":{"underlying":"Common Stock","underlying_shares":2636},"source":{"system":"sec-edgar","filing":"0001140361-18-036637","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118036637/form4.xml","form_type":"4"}},{"id":3839839,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-08-17T18:40:30.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":28043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments beginning on September 30, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":28043,"derivative":{"exercise_price":16.46,"expiration_date":"2028-08-15","underlying":"Common Stock","underlying_shares":28043},"source":{"system":"sec-edgar","filing":"0001140361-18-036637","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118036637/form4.xml","form_type":"4"}},{"id":3860769,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Unit","published_at":"2018-07-26T21:13:05.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":116576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":116576,"derivative":{"underlying":"Common Stock","underlying_shares":116576},"source":{"system":"sec-edgar","filing":"0001140361-18-033744","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118033744/form4.xml","form_type":"4"}},{"id":3860768,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":112209,"kind":"person","name":"Kendall Keith J","position":1,"cik":"0001406834","reported_name":"Kendall Keith J","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-07-26T21:13:05.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":240165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments beginning on August 31, 2018, subject in each case to Mr. Kendall's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":240165,"derivative":{"exercise_price":15,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":240165},"source":{"system":"sec-edgar","filing":"0001140361-18-033744","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406834/000114036118033744/form4.xml","form_type":"4"}}]}